In today's article, Indo Search Director Josh Craven looks at what is new in MedTech and HealthTech.
Dexcom has begun to roll out its G7 sensor, their rival glucose monitoring system to Abbott's FreeStyle Libre, by making the device available in the U.K., Ireland, Germany, Austria and Hong Kong. To learn more about Dexcom, click here.
Congratulations to Acurable for securing investment that will allow the company to build its distribution network to launch its sleep testing device across the EU/North America. Find out more about Acurable here.
Following the success of the Edison™ Accelerator 2021, GE Healthcare and Wayra collaborate with seven health tech startups to drive the digital transformation of healthcare across Europe, the Middle East and Africa.
Over the next six months, the seven startups will access GE Healthcare solutions, integrations, and healthcare providers to test their product innovations on existing workflows and technologies. Learn more here.
London-based Doccla, a health tech startup offering remote patient monitoring solutions to hospitals, announced Thursday that it had secured £15M (€16.7M) in an oversubscribed Series A round of funding.
HIMSS and WHO-Europe have signed a memorandum of understanding to bring paperless healthcare to the 53 member states of the WHO's European region. To read more, click here.
MHRA appointed the new UK Approved Body to certify medical devices since Brexit. Read the article here.
What is great news for the MedTech sector in Ireland? Johnson & Johnson Vision Care Ireland UC, a global leader in eye health and part of Johnson & Johnson MedTech, announced an expansion of its existing facility in Plassey, Limerick. The €100 million investment has the potential to create 80 new jobs and will support the company's ambition to redefine healthy sight for life for more people around the world. To read the article, click here.
Mental health funding of £1.8m welcomed by MHRA and NICE to explore the regulation of digital mental health tools.
There has been a significant increase in digital mental health tools on the market in recent years. However, these products present regulatory challenges, such as whether they are medical devices and, if so, which risk classification they would fall under. Learn more here.
Comments